Incyte Corporation (INCY), Pacific Biosciences of California (PACB), Astex Pharmaceuticals, Inc. (ASTX): 3 Humongous Health-Care Stocks This Week

Looking ahead

It’s quite possible that these three stocks might not enjoy humongous performance for too much longer. Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) warned that 2014 could present a more challenging environment with lower expected sales of Dacogen. My colleague Sean Williams suspects that PacBio’s stock might have surged too much considering its business realities. Incyte Corporation (NASDAQ:INCY) could easily drift back down some as well. The pancreatic cancer study results were great, but there’s still phase 3 to get past.

Overall, I like Incyte the most of this week’s top performers. Jakafi is already racking up solid sales and shows excellent potential for expanding beyond its currently approved indication. I also think there’s a decent chance that a larger player could have Incyte on its acquisition radar screen at some point. There could be plenty of ups and downs along the way, but this biotech could be one for investors to keep on their radar screens as well.

The article 3 Humongous Health-Care Stocks This Week originally appeared on Fool.com and is written by Keith Speights.

Fool contributor Keith Speights has no position in any stocks mentioned. The Motley Fool recommends Pacific Biosciences of California.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.